Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy



Status:Completed
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:18 - Any
Updated:11/8/2014
Start Date:April 2014
End Date:March 2015
Contact:Allergan Inc.
Email:clinicaltrials@allergan.com

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

This study will evaluate the safety and efficacy of cyclosporine 0.05% ophthalmic emulsion
(Restasis®) in patients with dry eye disease.


Inclusion Criteria:

- History of dry eye in both eyes

- Willing to use eye drops for dry eye symptoms

Exclusion Criteria:

- Anticipate wearing contact lenses during the study

- Laser-assisted in situ keratomileusis (LASIK) surgery within the past 12 months

- Any ocular and/or lid surgeries within the past 6 months

- Cataract surgery in either eye

- Current or anticipated use of temporary punctal plugs during the study
We found this trial at
1
site
Clinical Trial Facility in Andover Massachusetts
Andover, Massachusetts
?
mi
from
Andover, MA
Click here to add this to my saved trials